Evidence map›Paper›PMID 30809079›Full record

ReviewWorld journal of gastroenterology2019

Solutions for submucosal injection: What to choose and how to do it.

Rui Castro, Diogo Libânio, Inês Pita, Mário Dinis-Ribeiro

3 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04977401 naterminatednot on this mapstarted 2021, after this paper: background citation

EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection: a Randomized Controlled Multicentric Trial (EPSILON)

TypeinterventionalSponsorErasme University HospitalRan2021 to 2023Enrolled32ConditionsEarly Gastric Cancer, Rectal PolypArmsEndoscopic submucosal dissection, use of Orise Gel as lifting agent for endoscopic submucosal dissection, use of glycerol as lifting agent for endoscopic submucosal dissection
NCT05345613 phase4recruitingnot on this mapstarted 2022, after this paper: background citation

Usage of Tranexamic Acid During Colonic Endoscopic Resection Procedures for Reduction Intraprocedural and Postprocedural Bleeding

TypeinterventionalSponsorAssaf-Harofeh Medical CenterRan2022 to 2026Enrolled200ConditionsColon NeoplasmArmsTranexamic acid, Standard
NCT05688020 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

Comparison Between Epinephrine Versus Tranexamic Acid Usage During Upper Gastrointestinal Tract Endoscopic Resection Procedures for the Reduction of Intraprocedural and Postprocedural Bleeding

TypeinterventionalSponsorAssaf-Harofeh Medical CenterRan2023 to 2026Enrolled200ConditionsGastric Polyp, Gastric Neoplasm, Duodenal Neoplasms, Esophageal NeoplasmsArmsTranexamic acid, Epinephrine injection
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Unsuspected efficacy of starch-based polysaccharideWorld journal of gastrointestinal endoscopy · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rui CastroDepartment of Gastroenterology, Portuguese Oncology Institute of Porto, Porto 4450-590, Portugal. rui.arrais.castro@gmail.com.
Diogo LibânioDepartment of Gastroenterology, Portuguese Oncology Institute of Porto, Porto 4450-590, Portugal.
Inês PitaDepartment of Gastroenterology, Portuguese Oncology Institute of Porto, Porto 4450-590, Portugal.
Mário Dinis-RibeiroDepartment of Gastroenterology, Portuguese Oncology Institute of Porto, Porto 4450-590, Portugal.
Instituto Português de Oncologia Francisco Gentil · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the past decades, endoscopic resection techniques have gradually improved and gained more importance for the management of premalignant lesions and early cancers. These endoscopic resection techniques can be divided in 3 major groups: snare polipectomy, endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD). The use of submucosal injection is essential for the majority of EMR techniques and is an integral part of ESD, whereas during polipectomy it is not crucial in most cases except to prevent bleeding in large polyps and/or those with large stalks as an alternative to mechanical methods. Injection provides a lifting up effect of the lesion separating it from the muscular layer, thereby reducing thermal injury and the risk of perforation and bleeding while also facilitating

Indexed as

Endoscopic Mucosal ResectionGastric MucosaGastrointestinal DiseasesHumansInjectionsIntestinal MucosaNeoplasmsPrecancerous ConditionsEndoscopic mucosal resectionEndoscopic submucosal dissectionSnare polipectomySubmucosal injectionSubmucosal injection solution

Identifiers

PMID30809079
PMCPMC6385015
OpenAlexW2916833823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.